Title | Biomarkers- APSC Consensus & Future Use Case in Diabetes Mellitus and COVID-19 |
Date | 31 July 2020, Friday |
Time | 1200 - 1330 Singapore Time / 1300 - 1430 Japan Time / 0400 - 0530 GMT |
Registration is on first-come-first-served basis.
By registering for the Webinar, you agree to our Privacy Policy
Topics
APSC Consensus for Assessment of ACS Using high sensitivity Troponin T in ED - Assoc Prof Inoue Kenji
Implementation of 0/1 hour algorithm in Australia - The Real World Study, RAPID-TnT - Dr Cynthia Papendick
Role of NT-proBNP in T2DM patient - The ADOPT study - Dr Chanchal Chandramouli
COVID-19 Serology Tests - The Evidence & Future Use Case - Assoc Prof David Lye
Chair
Adj Assoc Prof Jack Tan
Deputy Head & Senior Consultant
National Heart Centre Singapore
President, Asian Pacific Society of Cardiology
Singapore
Speakers
Assoc Prof Inoue Kenji
Associate Professor, Department of Cardiology
Juntendo University Nerima Hospital
Japan
Dr Cynthia Papendick
Emergency Physician
Royal Adelaide Hospital
Australia
Dr Chanchal Chandramouli
Clinical Research Fellow
National Heart Centre Singapore
Singapore
Dr David Lye
Director, Infectious Disease Research and Training Office
National Centre for Infectious Diseases
Singapore
Panelists
Prof Evangelos Giannitsis
Senior Physician, Clinic for Cardiology, Angiology, Pneumology
Medical Director, Chest Pain Unit
Deputy Director, Private Outpatient Prof. Dr. HA Katus
Research Group Head, AG Cardiac Biomarker
University Hospital Heidelberg
Germany
Assoc Prof Sazzli Kasim
Cardiologist, Professor of Medicine and Hospital Director
UiTM Medical Specialist Centre
Malaysia
Dr Laila Abdel Wareth
Chief, Clinical Pathology
Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi
United Arab Emirates
Supported by